Related Experiment Videos
Atherosclerotic complications after renal transplantation
E Ritz1, V Schwenger, M Wiesel
1Department of Internal Medicine, University of Heidelberg, Germany.
Insights
Cardiac death is the leading cause of graft loss after kidney transplant, despite lower risks than other renal replacement therapies. Managing hypertension, dyslipidemia, and smoking can improve patient and graft survival.
Area of Science:
- Nephrology
- Cardiology
- Transplantation
Background:
- Cardiac death is the primary cause of long-term graft loss in kidney transplant recipients.
- While cardiovascular death risk is lower than other renal replacement therapies, it remains elevated compared to the general population.
Purpose of the Study:
- To identify factors influencing patient and graft survival in kidney transplant recipients.
- To explore strategies for reducing cardiovascular mortality and chronic allograft vasculopathy.
Main Methods:
- Analysis of factors predicting patient and graft survival.
- Review of cardiovascular risk factors in renal transplant patients.
Main Results:
- Hypertension, dyslipidemia, smoking, and hyperhomocysteinemia are key predictors of survival.
- Lowering blood pressure, statin use, smoking cessation, and folate administration are potential interventions.
Conclusions:
- Aggressive management of modifiable risk factors is crucial for improving outcomes.
- Targeted interventions may reduce cardiovascular mortality and slow chronic allograft vasculopathy progression.
Abstract:
Death with functioning graft, the most frequent cause being cardiac death, continues to be the most frequent cause of long-term graft loss. The risk of cardiovascular death in the transplanted patient is lower than in patients with other modalities of renal replacement therapy, but continues to be substantially higher than in the general population. Amongst the factors predicting patient and graft survival are hypertension, dyslipidemia, smoking and possibly hyperhomocysteinemia. It is concluded that lowering of blood pressure to levels far lower than levels accepted in the past, more widespread administration of statines, cessation of smoking and possibly administration of folate should reduce cardiovascular mortality and possibly also influence chronic allograft vasculopathy.